FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 40 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,129 | -99.9% | 341,972 | -16.7% | 0.11% | -9.8% |
Q1 2023 | $1,170,535 | -60.9% | 410,714 | 0.0% | 0.12% | -66.8% |
Q4 2022 | $2,989,998 | -10.0% | 410,714 | 0.0% | 0.37% | -10.2% |
Q3 2022 | $3,323,000 | +65.2% | 410,714 | 0.0% | 0.41% | +77.3% |
Q2 2022 | $2,012,000 | -79.3% | 410,714 | 0.0% | 0.23% | -76.2% |
Q1 2022 | $9,713,000 | +33.7% | 410,714 | 0.0% | 0.98% | +43.7% |
Q4 2021 | $7,266,000 | -37.3% | 410,714 | 0.0% | 0.68% | +0.4% |
Q3 2021 | $11,586,000 | +169.2% | 410,714 | 0.0% | 0.68% | +173.8% |
Q2 2021 | $4,304,000 | -11.0% | 410,714 | 0.0% | 0.25% | -8.1% |
Q1 2021 | $4,838,000 | +0.6% | 410,714 | 0.0% | 0.27% | +3.4% |
Q4 2020 | $4,809,000 | +47.7% | 410,714 | 0.0% | 0.26% | +45.8% |
Q3 2020 | $3,257,000 | -56.6% | 410,714 | 0.0% | 0.18% | -72.1% |
Q2 2020 | $7,512,000 | +53.2% | 410,714 | 0.0% | 0.64% | -16.4% |
Q1 2020 | $4,904,000 | -28.2% | 410,714 | 0.0% | 0.77% | +6.1% |
Q4 2019 | $6,834,000 | +150.6% | 410,714 | 0.0% | 0.72% | +184.6% |
Q3 2019 | $2,727,000 | – | 410,714 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $32,054,000 | 14.00% |
TRV GP IV, LLC | 2,343,154 | $18,956,000 | 11.08% |
Logos Global Management LP | 1,950,000 | $15,776,000 | 1.94% |
COWEN AND COMPANY, LLC | 2,347,989 | $18,995,000 | 1.82% |
VR Adviser, LLC | 1,200,000 | $9,708,000 | 1.50% |
RA Capital Management | 7,000,000 | $56,630,000 | 1.21% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,528,000 | $28,542,000 | 1.18% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $1,780,000 | 0.77% |
RTW INVESTMENTS, LP | 3,985,910 | $32,246,000 | 0.74% |
BRANDYWINE MANAGERS, LLC | 26,127 | $211,000 | 0.69% |